SHR-1701, a novel bifunctional anti-PD-L1/TGF-I2RII agent, for pretreated recurrent/refractory (r/r) gastric cancer (GC): data from a first-in-human phase 1 study
SHR-1701
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: SHR-1701, a novel bifunctional anti-PD-L1/TGF-I2RII agent, for pretreated recurrent/refractory (r/r) gastric cancer (GC): data from a first-in-human phase 1 study ### Output: SHR-1701